Voyageur Pharmaceuticals Ltd (VM) — Cash Flow-to-Debt Ratio
Voyageur Pharmaceuticals Ltd (VM) has a Cash Flow-to-Debt Ratio of -0.20x as of November 2025, meaning its operating cash flow of CA$-369.98K could theoretically repay 0% of its total liabilities (CA$1.85 Million) in one year. See VM free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Voyageur Pharmaceuticals Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Voyageur Pharmaceuticals Ltd across 15 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Voyageur Pharmaceuticals Ltd.
Annual Cash Flow-to-Debt Ratio for Voyageur Pharmaceuticals Ltd (2011–2025)
Year-by-year debt coverage analysis for Voyageur Pharmaceuticals Ltd. Check VM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.56x | CA$-2.89 Million | CA$1.85 Million | ▼ -1009.7% |
| 2024 | -0.14x | CA$-302.29K | CA$2.15 Million | ▲ +89.7% |
| 2023 | -1.36x | CA$-991.25K | CA$727.88K | ▲ +50.0% |
| 2022 | -2.72x | CA$-1.72 Million | CA$630.83K | ▼ -8.8% |
| 2021 | -2.50x | CA$-1.65 Million | CA$660.64K | ▼ -791.3% |
| 2020 | -0.28x | CA$-272.19K | CA$968.85K | ▲ +62.4% |
| 2019 | -0.75x | CA$-637.81K | CA$852.69K | ▼ -14.5% |
| 2018 | -0.65x | CA$-490.45K | CA$750.79K | ▼ -0.4% |
| 2017 | -0.65x | CA$-624.24K | CA$959.12K | ▲ +27.9% |
| 2016 | -0.90x | CA$-35.07K | CA$38.86K | ▲ +88.1% |
| 2015 | -7.61x | CA$-70.65K | CA$9.28K | ▼ -2424.0% |
| 2014 | -0.30x | CA$-23.66K | CA$78.45K | ▲ +95.3% |
| 2013 | -6.38x | CA$-54.73K | CA$8.58K | ▼ -6561.2% |
| 2012 | 0.10x | CA$2.32K | CA$23.47K | ▲ +107.4% |
| 2011 | -1.33x | CA$-28.19K | CA$21.21K | — |